Results 31 to 40 of about 3,817,010 (199)
Containing 2019-nCoV (Wuhan) coronavirus [PDF]
The novel coronavirus 2019-nCoV first appeared in December 2019 in Wuhan, China. While most of the initial cases were linked to the Huanan Seafood Wholesale Market, person-to-person transmission has been verified. Given that a vaccine cannot be developed and deployed for at least a year, preventing further transmission relies upon standard principles ...
openaire +3 more sources
Emergence of novel coronavirus-2019 has become an international health concern. The objective of this review is to focus on 2019-nCoV emergence, prophylaxis and to predict the treatment approaches.
Muhammad Salman Rasool +3 more
doaj +1 more source
The legal class B infectious disease - the 2019 novel coronavirus (2019-nCoV) infected pneumonia in Wuhan, China: a review [PDF]
On January 20, 2020, the National Health Commission of the People's Republic of China issued the No. 1 document of 2020, which officially incorporated the 2019 novel coronavirus (2019-nCoV) infected pneumonia into the Class B infectious diseases ...
Li LI +3 more
doaj +1 more source
In-silico Immunomodelling of 2019-nCoV [PDF]
Abstract Background: Novel Corona Virus 2019 (2019-nCoV) is a positive-sense single-strand RNA virus form coronaviridae family, responsible for corona virus infectious disease 2019 (COVID-19) with rapid transmission. The aim of this study is characterization of major viral proteins, prediction of antigen proteasomal cleavage pattern, MHC class ...
Maali A +4 more
europepmc +2 more sources
Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov
A novel coronavirus, called 2019-nCoV, was recently found in Wuhan, Hubei Province of China, and now is spreading across China and other parts of the world.
Yi Pan (68170) +8 more
core +1 more source
2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus
2019 Novel Coronavirus (2019-nCoV) is an emerging infectious disease closely related to MERS-CoV and SARS-CoV that was first reported in Wuhan City, Hubei Province, China in December 2019.
Kristi L. Koenig +2 more
doaj +1 more source
Maintaining proper health records improves machine learning predictions for novel 2019-nCoV
Background An ongoing outbreak of a novel coronavirus (2019-nCoV) pneumonia continues to affect the whole world including major countries such as China, USA, Italy, France and the United Kingdom.
Koffka Khan, Emilie Ramsahai
doaj +1 more source
Heparins and 2019-nCoV infection: a narrative review. [PDF]
Patients with 2019-nCoV infection have a high risk to develop venous thrombotic events. Several guidelines recommend the use of either unfractionated heparin or low molecular weight heparins in preventing thrombotic events in these patients. However, results from clinical studies, so far published, reached controversial conclusions on heparin efficacy ...
Doris BARCELLONA +6 more
openaire +2 more sources
. Background:. Medicines for the treatment of 2019-novel coronavirus (2019-nCoV) infections are urgently needed. However, drug screening using live 2019-nCoV requires high-level biosafety facilities, which imposes an obstacle for those institutions ...
Hua-Hao Fan +8 more
doaj +1 more source
Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 [PDF]
Since December 2019, China has been experiencing a large outbreak of a novel coronavirus (2019-nCoV) which can cause respiratory disease and severe pneumonia.
Althaus, Christian L +6 more
core +2 more sources

